Ganesh Mugundu

5PUBLICATIONS
25CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersFood properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 20, 2024
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors.

Martin Johnson, Daniel Kaschek, Dana Ghiorghiu

|Nov 27, 2023
Longitudinal Circulating Tumor DNA Modeling to Predict Disease Progression in First-Line Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer.

Martin Johnson, Carlos Serra Traynor, Karthick Vishwanathan

|Jun 06, 2023
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.

Todd M Bauer, Kathleen N Moore, Janet S Rader

|Jun 20, 2020
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors.

Mats Någård, Mei-Lin Ah-See, Karen So

|Dec 12, 2018
Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology.

Mark Farha, Eric Masson, Helen Tomkinson

Pageof 1

Frequent Collaborators

2 joint publications

Martin Johnson

1 joint publications

Carlos Serra Traynor

1 joint publications

Karthick Vishwanathan

1 joint publications

Philip Overend